That is absolutely true , at some point in critical patients , the cytokine and VL going down in patients after the treatment WITH leronlimab , but patient died ..To much damage already done.
This what happened with our first 11 INDs patients in Montefiore.
In all 11 patients blood tests started to improve by 3 day , but some died anyway.
But at the same time so many coming off the ventilators and ECMO without the problems after the leronlimab , that it is worth to try.
All IMO.